LATE-BREAKING ABSTRACT: Single-dose safety, tolerability, PD & PK of AZD8999, a bi-functional muscarinic antagonist/β2-agonist (MABA), in patients with COPD

  • Dave Singh, Tim Mant, Helena Pujol, Èric Massana, Meritxell Falques, Marisa Gonzalez, Carol Astbury
  • European Respiratory Journal, September 2016, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.congress-2016.oa3307

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1183/13993003.congress-2016.oa3307

In partnership with:

Link to European Respiratory Society (ERS) showcase